Lincoln Pharmaceuticals Limited

NSE:LINCOLN India Drug Manufacturers - Specialty & Generic
Market Cap
$139.30 Million
₹12.06 Billion INR
Market Cap Rank
#20182 Global
#1017 in India
Share Price
₹602.30
Change (1 day)
-2.49%
52-Week Range
₹444.20 - ₹654.30
All Time High
₹953.70
About

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It … Read more

Lincoln Pharmaceuticals Limited (LINCOLN) - Total Liabilities

Latest total liabilities as of September 2025: ₹1.39 Billion INR

Based on the latest financial reports, Lincoln Pharmaceuticals Limited (LINCOLN) has total liabilities worth ₹1.39 Billion INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Lincoln Pharmaceuticals Limited - Total Liabilities Trend (2006–2025)

This chart illustrates how Lincoln Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Lincoln Pharmaceuticals Limited Competitors by Total Liabilities

The table below lists competitors of Lincoln Pharmaceuticals Limited ranked by their total liabilities.

Company Country Total Liabilities
The Hain Celestial Group Inc
NASDAQ:HAIN
USA $1.15 Billion
NNIT A/S
LSE:0R5Z
UK Dkr1.65 Billion
High Tech Pharm Co. Ltd
KQ:106190
Korea ₩12.57 Billion
Cox Energy América, S.A.B. de C.V.
MC:COXE
Spain €10.33 Billion
Wieson Technologies Co Ltd
TWO:6272
Taiwan NT$2.52 Billion
UBcare. Co. Ltd
KQ:032620
Korea ₩72.26 Billion
Cabral Gold Inc
PINK:CBGZF
USA $1.78 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Lincoln Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.02 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lincoln Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lincoln Pharmaceuticals Limited (2006–2025)

The table below shows the annual total liabilities of Lincoln Pharmaceuticals Limited from 2006 to 2025.

Year Total Liabilities Change
2025-03-31 ₹1.25 Billion +16.64%
2024-03-31 ₹1.07 Billion +26.50%
2023-03-31 ₹849.46 Million -16.29%
2022-03-31 ₹1.01 Billion +18.05%
2021-03-31 ₹859.67 Million +13.24%
2020-03-31 ₹759.17 Million -20.54%
2019-03-31 ₹955.43 Million -22.13%
2018-03-31 ₹1.23 Billion +8.91%
2017-03-31 ₹1.13 Billion -15.97%
2016-03-31 ₹1.34 Billion -6.76%
2015-03-31 ₹1.44 Billion -8.55%
2014-03-31 ₹1.57 Billion +9.65%
2013-03-31 ₹1.43 Billion +10.24%
2012-03-31 ₹1.30 Billion +47.04%
2011-03-31 ₹884.65 Million +53.47%
2010-03-31 ₹576.43 Million +57.54%
2009-03-31 ₹365.89 Million +26.62%
2008-03-31 ₹288.97 Million +8.75%
2007-03-31 ₹265.73 Million +4.56%
2006-03-31 ₹254.13 Million --